↓ Skip to main content

Dove Medical Press

Ketamine and depression: a narrative review

Overview of attention for article published in Drug Design, Development and Therapy, August 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 2,296)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
28 news outlets
blogs
4 blogs
twitter
13 X users
facebook
2 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
387 Mendeley
Title
Ketamine and depression: a narrative review
Published in
Drug Design, Development and Therapy, August 2019
DOI 10.2147/dddt.s221437
Pubmed ID
Authors

Alexandrine Corriger, Gisèle Pickering

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 387 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 387 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 69 18%
Student > Master 41 11%
Researcher 31 8%
Student > Ph. D. Student 23 6%
Other 14 4%
Other 37 10%
Unknown 172 44%
Readers by discipline Count As %
Medicine and Dentistry 60 16%
Neuroscience 40 10%
Pharmacology, Toxicology and Pharmaceutical Science 25 6%
Psychology 24 6%
Biochemistry, Genetics and Molecular Biology 21 5%
Other 34 9%
Unknown 183 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 244. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2024.
All research outputs
#155,534
of 25,837,817 outputs
Outputs from Drug Design, Development and Therapy
#15
of 2,296 outputs
Outputs of similar age
#2,901
of 362,303 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 47 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,303 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.